Negative Estrogen Receptors and Negative Progesterone Receptors

Oct 13, 2025 by windailys.com 99 views

Breast Cancer Clinicopathology Based on Neutrophil Levels at the Adam Malik Hajj General Hospital in Medan in 2018-2021

Breast cancer is a leading cause of cancer-related deaths worldwide, and its incidence is increasing globally. In Indonesia, breast cancer is the most common type of cancer among women, accounting for a significant proportion of cancer-related deaths. The disease is characterized by the uncontrolled growth of abnormal cells in the breast tissue, leading to the formation of tumors. Understanding the clinicopathological features of breast cancer is crucial for developing effective treatment strategies and improving patient outcomes.

The Importance of Neutrophil Levels in Breast Cancer Clinicopathology

Neutrophil levels have been identified as a potential prognostic factor for breast cancer. Neutrophils are a type of white blood cell that plays a crucial role in the body's immune response. In the context of breast cancer, high neutrophil levels have been associated with aggressive tumor behavior, increased metastatic potential, and poor patient outcomes. Therefore, it is essential to investigate the relationship between neutrophil levels and breast cancer clinicopathology to better understand the disease's mechanisms and develop more effective treatment strategies.

Methodology and Results

This study aimed to determine the clinical picture of breast cancer clinicopathology based on neutrophil levels at the Adam Malik Hajj General Hospital in Medan during the 2018-2021 period. The study used an observational descriptive method with analysis using the lemeshow formula. The results showed that most patients were aged 40-49 years, had high school education, worked as housewives, had no family history of breast cancer, had grade II tumors, and had high neutrophil levels.

Analysis of Results

The results of this study showed a significant association between high neutrophil levels and various clinicopathological features of breast cancer, including:

Tumor Infiltrating Lymphocytes (TILs) Weight: High neutrophil levels were associated with a decrease in the ability of TILs to suppress tumor growth, leading to more aggressive tumor behavior.
Metastasis: High neutrophil levels were associated with an increased risk of metastasis, as neutrophils can help cancer cells to spread to other organs.
Angioinvation Positive: High neutrophil levels were associated with an increase in the formation of new blood vessels that can be used by cancer cells to spread to other organs.
Negative Estrogen Receptors and Negative Progesterone Receptors: High neutrophil levels were associated with the inability of cancer cells to respond to hormonal therapy.
HER2 1+: High neutrophil levels were associated with increased HER2 expression, indicating aggressive tumor growth.
Ki-67 Positive: High neutrophil levels were associated with an increase in the growth rate of cancer cells.

Implications

This study provides important information about the relationship between neutrophil levels and breast cancer clinicopathology. The findings of this study can help in understanding the mechanisms of breast cancer development and determining more effective treatment strategies. Further research is needed to confirm this relationship and to determine the right intervention strategy, such as anti-inflammatory therapy, to modulate neutrophil levels and improve patient outcomes.

Conclusion

In conclusion, this study highlights the importance of neutrophil levels in breast cancer clinicopathology. The findings of this study suggest that high neutrophil levels are associated with aggressive tumor behavior, increased metastatic potential, and poor patient outcomes. Further research is needed to confirm this relationship and to develop more effective treatment strategies for breast cancer patients.

Recommendations

Based on the findings of this study, the following recommendations are made:

Further research is needed to confirm the relationship between neutrophil levels and breast cancer clinicopathology.
Anti-inflammatory therapy should be considered as a potential intervention strategy to modulate neutrophil levels and improve patient outcomes.
Clinicians should be aware of the potential prognostic value of neutrophil levels in breast cancer patients and consider incorporating this factor into treatment decisions.

Limitations

This study has several limitations, including:

The study was conducted at a single hospital, which may limit the generalizability of the findings.
The study used a retrospective design, which may be subject to biases and limitations.
Further research is needed to confirm the relationship between neutrophil levels and breast cancer clinicopathology.

Future Directions

Future research should focus on:

Confirming the relationship between neutrophil levels and breast cancer clinicopathology.
Developing more effective treatment strategies for breast cancer patients, including anti-inflammatory therapy.
Investigating the potential prognostic value of neutrophil levels in breast cancer patients.

References

[List of references cited in the study]

Appendix

[Appendix materials, including tables, figures, and additional data]
Breast Cancer Clinicopathology Based on Neutrophil Levels: A Q&A Article

In our previous article, we discussed the relationship between neutrophil levels and breast cancer clinicopathology. To provide further clarity and insights, we have compiled a list of frequently asked questions (FAQs) and answers related to this topic.

Q: What is the significance of neutrophil levels in breast cancer?

A: Neutrophil levels have been identified as a potential prognostic factor for breast cancer. High neutrophil levels have been associated with aggressive tumor behavior, increased metastatic potential, and poor patient outcomes.

Q: What are the clinicopathological features of breast cancer associated with high neutrophil levels?

A: The results of this study showed a significant association between high neutrophil levels and various clinicopathological features of breast cancer, including:

Tumor Infiltrating Lymphocytes (TILs) Weight
Metastasis
Angioinvation Positive
Negative Estrogen Receptors and Negative Progesterone Receptors
HER2 1+
Ki-67 Positive

Q: What is the potential mechanism by which high neutrophil levels contribute to breast cancer progression?

A: High neutrophil levels may contribute to breast cancer progression by:

Suppressing the immune response and allowing cancer cells to grow and spread
Promoting angiogenesis and metastasis
Inhibiting the effectiveness of hormonal therapy
Increasing the expression of HER2 and promoting aggressive tumor growth

Q: What are the implications of this study for breast cancer treatment and management?

A: The findings of this study suggest that high neutrophil levels may be a useful prognostic factor for breast cancer patients. Clinicians should consider incorporating neutrophil levels into treatment decisions and developing more effective treatment strategies, such as anti-inflammatory therapy, to modulate neutrophil levels and improve patient outcomes.

Q: What are the limitations of this study?

A: This study has several limitations, including:

The study was conducted at a single hospital, which may limit the generalizability of the findings
The study used a retrospective design, which may be subject to biases and limitations
Further research is needed to confirm the relationship between neutrophil levels and breast cancer clinicopathology

Q: What are the future directions for research on this topic?

A: Future research should focus on:

Confirming the relationship between neutrophil levels and breast cancer clinicopathology
Developing more effective treatment strategies for breast cancer patients, including anti-inflammatory therapy
Investigating the potential prognostic value of neutrophil levels in breast cancer patients

Q: What are the potential benefits of incorporating neutrophil levels into breast cancer treatment and management?

A: Incorporating neutrophil levels into breast cancer treatment and management may lead to:

Improved patient outcomes and survival rates
More effective treatment strategies and reduced side effects
Enhanced understanding of the mechanisms of breast cancer progression and development

Q: What are the potential challenges and limitations of incorporating neutrophil levels into breast cancer treatment and management?

A: Incorporating neutrophil levels into breast cancer treatment and management may be challenging due to:

Limited availability of neutrophil level data
Variability in neutrophil level measurement and interpretation
Potential biases and limitations in study design and analysis

Q: What are the next steps for research on this topic?

A: The next steps for research on this topic should include:

Conducting larger and more diverse studies to confirm the relationship between neutrophil levels and breast cancer clinicopathology
Developing and validating more accurate and reliable methods for measuring neutrophil levels
Investigating the potential benefits and limitations of incorporating neutrophil levels into breast cancer treatment and management.